IronCh Cancer Research Results
IronCh, Iron Chelator: Click to Expand ⟱
| Source: |
| Type: |
Iron Chelator
|
Scientific Papers found: Click to Expand⟱
*toxicity∅, *antiOx↑, IronCh↑,
| - |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
TfR1/CD71↑, IRP1↑, IronCh↑, Casp↑, eff↑,
Ferritin↓, IronCh↑, TumAuto↑, Apoptosis↑, eff↝, Dose↝,
IronCh↑, TfR1/CD71↑, FTH1↓,
ROS↑, IronCh↑, Apoptosis↑,
AntiCan↑, Imm↑, antiOx↑, TumCP↓, Diff↑, TumCG↓, eff↑, P21↓, p27/CDKN1B↓, pRB↓, TumCCA↑, PI3K↓, Akt↓, PKCδ↓, RAS↓, ERK↓, NF-kB↓, Inflam↓, MMP9↓, IronCh↑, NK cell↑, selectivity↑, ChemoSen↑, chemoP↑, toxicity↓, Remission↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
IronCh↑, ROS↓, Imm↑, Inflam↓, *BBB↑, Iron↝, *Fenton↓, *ROS↓, *TAC↑, *SOD↑, *GPx↑, *GSH↑, *TBARS↓, *PTEN↓, *tau↓, *MAPK↓, *Aβ42↓, *Apoptosis↓, *Casp3↓, *Akt↑, *GutMicro↑, *Sepsis↓, *anemia↓, *IL6↓, *FPN↑, *TfR1/CD71↑, *Ferritin↓, *HemoG↑, *RBC↑, *eff↑, *BioAv↓, *BioAv↑, *BioAv↝, *ChemoSen↑, *BioAv↑, Ferroptosis↑,
ROS↑, Apoptosis↑, cl‑Casp3↑, cl‑Casp9↑, Ferroptosis↑, NRF2↓, GPx4↓, IronCh↑,
ROS↑, TumCCA↑, TumCP↓, angioG↓, ER Stress↑, mtDam↑, PERK↑, ATF4↑, eIF2α↑, cl‑Casp12↑, EMT↓, E-cadherin↑, N-cadherin↓, Vim↓, *neuroP↑, NF-kB↓, PI3K↓, Akt↑, XIAP↓, MMP↓, Ca+2↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, Cyt‑c↑, IronCh↑, SOD↓, *ROS↓, *LDHA↑, *SOD↑, *GSH↑, *BioAv↓, Telomerase↓, cMyc↓, hTERT/TERT↓, DR5↑, Fas↑, FADD↑, BAD↑, BOK↑, BID↑, NAIP↓, Mcl-1↓, CDK2↓, CDK4↓, MAPK↓, AKT1↓, Akt2↓, *Beclin-1/ATG6↓, Hif1a↓, LC3II↑, Beclin-1/ATG6↑,
IronCh↑, ROS↑,
*hepatoP↑, *ROS↓, *GSH↑, *BioAv↝, ERK↓, NF-kB↓, STAT3↓, COX2/PTGS2↓, Inflam↓, IronCh↑, lipid-P↓, ALAT↓, AST↓, TNF-α↓, *α-SMA↓, *SOD↑,
*antiOx↑, *ROS↓, *cardioP↑, *BioAv↓, *Half-Life↝, *other↑, IronCh↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
Obesity, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
*antiOx↑, *ROS↓, *Inflam↓, *Bacteria↓, AntiTum↑, IronCh↑, *HDL↑, *LDL↓, *BioAv↝, *Half-Life↝, *BioAv↑, *SOD↑, *GPx↑, *GSTs↑, *eff↑, radioP↑, *MDA↓, *other↑, *COX1↓, *COX2/PTGS2↓, *AntiAg↑, *RNS↓, *NO↓, *H2O2↓, *NOS2↓, *NADH↓, *Imm↑, Apoptosis↑, TumCP↓, angioG↓, TumCMig↓, Ca+2↑, TumCCA↑, DNAdam↑, BAX↑, Casp9↑, Casp8↑, Casp3↑, cl‑PARP↑, AIF↑, i-ROS↑, MMP↓, Cyt‑c↑, APAF1↑, Ca+2↑, MMP9↓, MMP2↓, PKCδ↓, ERK↓, H2O2↑, BAX↑, Bcl-2↓, DNAdam↑, lipid-P↑, ChemoSen↑, chemoP↑, *cardioP↑, *SOD↑, *Catalase↑, *GPx↑, *GSH↑, *BP↓, *AntiDiabetic↑, *Obesity↓, RenoP↑, *GastroP↑, hepatoP↑, *AChE↓, *cognitive↑, *BChE↓, *other↓, *BioAv↑,
Showing Research Papers: 1 to 13 of 13
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 13
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, Ferroptosis↑, 2, GPx4↓, 1, H2O2↑, 1, Iron↝, 1, IRP1↑, 1, lipid-P↓, 1, lipid-P↑, 1, NRF2↓, 1, ROS↓, 1, ROS↑, 4, i-ROS↑, 1, SOD↓, 1,
Metal & Cofactor Biology(tgid=2) ⓘ
Ferritin↓, 1, FTH1↓, 1, IronCh↑, 13, TfR1/CD71↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
AIF↑, 1, BOK↑, 1, MMP↓, 2, mtDam↑, 1, XIAP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AKT1↓, 1, ALAT↓, 1, cMyc↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Akt↑, 1, APAF1↑, 1, Apoptosis↑, 4, BAD↑, 1, BAX↑, 3, Bcl-2↓, 2, BID↑, 1, Casp↑, 1, cl‑Casp12↑, 1, Casp3↑, 2, cl‑Casp3↑, 1, Casp8↑, 1, Casp9↑, 2, cl‑Casp9↑, 1, Cyt‑c↑, 2, DR5↑, 1, FADD↑, 1, Fas↑, 1, Ferroptosis↑, 2, hTERT/TERT↓, 1, MAPK↓, 1, Mcl-1↓, 1, NAIP↓, 1, p27/CDKN1B↓, 1, Telomerase↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
pRB↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
eIF2α↑, 1, ER Stress↑, 1, PERK↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1/ATG6↑, 1, LC3II↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 2, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, CDK4↓, 1, P21↓, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Diff↑, 1, EMT↓, 1, ERK↓, 3, PI3K↓, 2, RAS↓, 1, STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Akt2↓, 1, Ca+2↑, 3, E-cadherin↑, 1, MMP2↓, 1, MMP9↓, 2, N-cadherin↓, 1, PKCδ↓, 2, TumCMig↓, 1, TumCP↓, 3, Vim↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 2, ATF4↑, 1, Hif1a↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, Imm↑, 2, Inflam↓, 3, NF-kB↓, 3, NK cell↑, 1, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 2, Dose↝, 1, eff↑, 2, eff↝, 1, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, Ferritin↓, 1, hTERT/TERT↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiTum↑, 1, chemoP↑, 2, hepatoP↑, 1, radioP↑, 1, Remission↑, 1, RenoP↑, 1, toxicity↓, 1,
Total Targets: 107
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
anemia↓, 1, Aβ42↓, 1, FPN↑, 1, RBC↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 3, Catalase↑, 1, Fenton↓, 1, GPx↑, 3, GSH↑, 4, GSTs↑, 1, H2O2↓, 1, HDL↑, 1, MDA↓, 1, NADH↓, 1, RNS↓, 1, ROS↓, 5, SOD↑, 5, TAC↑, 1, TBARS↓, 1,
Metal & Cofactor Biology(tgid=2) ⓘ
Ferritin↓, 1, TfR1/CD71↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
LDHA↑, 1, LDL↓, 1,
Cell Death(tgid=5) ⓘ
Akt↑, 1, Apoptosis↓, 1, Casp3↓, 1, MAPK↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↓, 1, other↑, 2,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1/ATG6↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
PTEN↓, 1,
Migration(tgid=13) ⓘ
AntiAg↑, 1, α-SMA↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
NO↓, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 1, GastroP↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX1↓, 1, COX2/PTGS2↓, 1, IL6↓, 1, Imm↑, 1, Inflam↓, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
AChE↓, 1, BChE↓, 1, tau↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 3, BioAv↑, 4, BioAv↝, 3, ChemoSen↑, 1, eff↑, 2, Half-Life↝, 2,
Clinical Biomarkers(tgid=22) ⓘ
BP↓, 1, Ferritin↓, 1, GutMicro↑, 1, HemoG↑, 1, IL6↓, 1, NOS2↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, cardioP↑, 2, cognitive↑, 1, hepatoP↑, 1, neuroP↑, 1, Obesity↓, 1, toxicity∅, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1, Sepsis↓, 1,
Total Targets: 65
Scientific Paper Hit Count for: IronCh, Iron Chelator
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:835 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page